Generated by GPT-5-mini| Spanish Society of Medical Oncology | |
|---|---|
| Name | Spanish Society of Medical Oncology |
| Native name | Sociedad Española de Oncología Médica |
| Abbreviation | SEOM |
| Formation | 1980 |
| Headquarters | Madrid, Spain |
| Region served | Spain |
| Membership | Medical oncologists |
| Leader title | President |
Spanish Society of Medical Oncology is a professional association based in Madrid that represents medical oncologists across Spain and engages with international oncology networks. The society interacts with institutions such as Ministry of Health (Spain), European Society for Medical Oncology, World Health Organization, European Commission, and Organisation for Economic Co-operation and Development to influence cancer care policy, research funding, and clinical practice. It collaborates with clinical centers including Hospital Universitario La Paz, Hospital Clínic de Barcelona, Hospital 12 de Octubre, Instituto de Investigación Sanitaria La Fe, and academic institutions like Complutense University of Madrid, University of Barcelona, Autonomous University of Madrid, University of Valencia, and University of Navarra.
Founded in 1980, the society developed amid reforms affecting Spanish Constitution of 1978 implementation, interactions with regional health services such as Servicio Madrileño de Salud, and expansion of specialty training organized by the Spanish Medical Colleges Organization. Early leaders included oncology clinicians connected to Instituto Catalán de Oncología and researchers from Centro Nacional de Investigaciones Oncológicas. Over decades the society responded to milestones like Spain’s accession to the European Union, adoption of European directives impacting clinical trials such as the Clinical Trials Directive 2001/20/EC, and national cancer plans like the National Health System (Spain) strategic frameworks. It has since grown alongside oncology advances characterized at congresses paralleling meetings of the American Society of Clinical Oncology, European Cancer Organisation, and symposia involving groups like Spanish Association Against Cancer.
The society’s mission emphasizes improvement of patient outcomes by promoting standards comparable to those advocated by European Society for Medical Oncology, American Society of Clinical Oncology, Union for International Cancer Control, National Cancer Institute (Spain), and regional cancer institutes. Objectives include development of clinical guidelines akin to initiatives by NICE, coordination with regulatory bodies like the Spanish Agency for Medicines and Health Products, fostering translational research with entities such as Centro Nacional de Investigaciones Oncológicas, and advocating for equitable access reflected in policies debated at forums like the Parliament of Spain. It aims to align practice with evidence emerging from trials registered with European Medicines Agency, reported in journals such as The Lancet Oncology, Journal of Clinical Oncology, and communicated at conferences like ASCO Annual Meeting.
Membership comprises medical oncologists trained under pathways recognized by the Spanish Ministry of Education and Vocational Training and accredited hospitals including Hospital Universitario y Politécnico La Fe and Hospital Universitario Gregorio Marañón. Governance includes an executive board with officers drawn from academic centers including University Hospital Virgen del Rocío, advisory committees liaising with research groups such as Grupo Español de Investigación en Cáncer de Mama (GEICAM), cooperatives like Grupo Español de Investigación en Cáncer Digestivo (GISCAD), and patient organizations like Spanish Federation of Cancer Patients (FECEC). The structure interfaces with specialty committees modeled on bodies such as European Medicines Agency advisory panels and regional scientific societies including Sociedad Catalana de Oncología.
The society organizes annual congresses featuring presentations from investigators affiliated with Centro de Investigación Médica Aplicada, panels similar to those at European Society for Medical Oncology Congress, and workshops in collaboration with institutions like Instituto de Salud Carlos III. Programs include quality initiatives paralleling those of Joint Commission International, oncology registries linked to National Cancer Registry (Spain), and campaigns coordinated with World Health Organization projects. It convenes multidisciplinary tumor boards reflecting practice at centers such as Hospital Virgen de la Arrixaca, sponsors multicenter clinical trials conducted with partners like Spanish Clinical Research Network, and supports survivorship initiatives comparable to programs from Macmillan Cancer Support.
The society develops evidence-based guidelines informed by randomized trials from cooperative groups including EORTC, European Organisation for Research and Treatment of Cancer, and publishes recommendations in journals analogous to Clinical & Translational Oncology and proceedings similar to those of Annals of Oncology. It fosters investigator-initiated studies with collaborators such as Centro Nacional de Investigaciones Oncológicas and pharmaceutical partners evaluated by Spanish Agency for Medicines and Health Products. Outputs include clinical practice guidelines, position statements on real-world evidence, and consensus documents drawing on data from registries like the Spanish Network of Cancer Registries (REDECAN), with dissemination at meetings akin to ASCO and ESMO.
Educational activities comprise postgraduate courses accredited by bodies such as the National Commission for the Training of Specialists, fellowships hosted in hospitals like Hospital Universitario Ramón y Cajal, and continuing medical education modeled on programs from European School of Oncology. The society collaborates with universities including University of Salamanca and training networks like European School of Oncology to provide master’s programs, certification courses, and mentorship schemes linked to research groups such as Spanish Cooperative Group on Colorectal Cancer (GCCG).
International engagement includes partnerships with European Society for Medical Oncology, World Health Organization, Union for International Cancer Control, International Agency for Research on Cancer, and participation in EU research frameworks like Horizon 2020. Advocacy efforts involve dialogues with institutions such as the European Commission, national legislators in the Cortes Generales, and collaborations with patient advocacy groups like Spanish Federation of Cancer Patients (FECEC) to address access to novel therapies, standards for clinical trials, and national cancer control strategies. Category:Medical associations based in Spain